In the mitogenic signaling cascade interaction of Ras with Raf represents a critical step for the regulation of cell growth and dierentiation. The major eector of Ras, the serine/threonine kinase Raf exists as three isoforms with dierent tissue distributions. We demonstrate that transient transfection of oncogenic Ha-Ras leads to a preferential activation of endogenous c-Raf-1 in HEK 293 cells as opposed to A-Raf. In vitro binding studies using puri®ed Ras binding domains of Raf as well as in vivo bindings tests with full length molecules reveals signi®cantly lower binding anities of A-Raf to Ha-Ras as compared to other Raf isoforms. The Ras-binding interface of c-Raf diers from A-Raf by a conservative Arg to Lys exchange at residue 59 or 22 respectively. Mutational analysis reveals that this residue represents a point of isozyme discrimination: c-Raf-R59K binds HaRas weaker than the wildtype, likewise A-Raf-K22R increases its anity to Ha-Ras in vivo and in vitro. Dierential binding anities are re¯ected in downstream signaling. Immunecomplex kinase assays reveal that HaRas mediated Raf activation is decreased for c-Raf-R59K and increased for A-Raf-K22R when compared to the respective wildtype forms. Thus our observations introduce a new level of isoform discrimination in Ras/ Raf signaling as a functional consequence of a conservative amino acid exchange in the Ras binding domains.
Introduction
The interaction of p21
Ras with its main eector kinase Raf is a crucial step in transducing extracellular signals to the nucleus. Signaling through the mitogenic Ras/ Raf/MEK/ERK pathway induces growth and differentiation depending on the cellular background (Daum et al., 1994; Kerckho and Rapp 1998) . In nonvertebrates, such as Caenorhabiditis elegans or Drosophila melanogaster, only one homolog of Raf appears to be expressed, suggesting a linear mechanism of signal ampli®cation (Dickson and Hafen, 1994) . In mammals three isoforms of Raf, c-Raf-1, A-Raf and BRaf, are encoded suggesting that the speci®city of Ras signaling in those cells which express the dierent isozymes of Raf is governed by a more complex mechanism (Rapp et al., 1988; Sithanandam et al., 1990; Beck et al., 1987) . Virtually all members of the Ras family of proteins share the capability of interacting with all three Raf isozymes, although what regulates the speci®city of this interaction is largely unknown.
Raf isozymes share a common architecture consisting of three highly conserved regions: CR1, CR2 and CR3 (for review see Slupsky et al., 1998) . The regulatory domain includes CR1 and 2, containing the Ras binding domain (RBD) and cysteine rich region (CRD) which forms a C1 zinc binding domain (Hurley et al., 1997) . Both the RBD and the CRD contribute to Ras-mediated signaling through Raf (Zhang et al., 1993; Bruder et al. 1992; Brtva et al., 1995) . Interaction with Ras is crucial for the recruitment of Raf to the plasma membrane where it achieves full catalytic activity (Leevers et al., 1994; Stokoe et al., 1994; Wittinghofer and Nassar, 1996) . We previously demonstrated that Raf-RBD binding anity to Ras correlates with activation of c-Raf-1 . However, the precise mechanism which modulates Raf activity at the plasma membrane remains unclear and much controversy surrounds the issue of whether Ras is able to directly mediate Raf activation, or to what extent other factors in the membrane are involved (Sternberg and Alberola-Ila, 1998) . The role of the dierent Raf isozymes within this milieu is not well understood. Marais et al. (1997) have demonstrated that B-Raf, which lacks the corresponding tyrosine residues of c-Raf or A-Raf, can be fully activated by v-Ras alone, whereas A-Raf and c-Raf-1 both require additional tyrosine phosphorylation. In the present study, we present data suggesting an additional mechanism of Raf isozymespeci®c regulation. We found that oncogenic Ha-Ras preferentially activates endogenous c-Raf as compared to A-Raf. This preference in signaling correlates with reduced binding anity of Ha-Ras for A-Raf in vitro and in vivo. We further demonstrate that the distinct binding anities in part due to a conservative amino acid dierence between residue 59 of c-Raf-1 and 22 of A-Raf respectively since mutations at this residue signi®cantly in¯uence downstream signaling.
Results
Oncogenic Ha-Ras preferentially stimulates endogenous c-Raf-1
We investigated the eects of active Ha-Ras on Raf isoforms in HEK293 cells. This cell line was used because we found considerable amounts of endogenous A-Raf and c-Raf-1. Using isoform speci®c antibodies, we determined, in parallel, the activation of endogenous c-Raf-1 and A-Raf in HEK293 cells by immunocomplex kinase assays ( Figure 1 ). As expected, transient transfection with increasing amounts of active Ras (Ha-Ras-G12V) leads to a dose dependent increase in activity of endogenous cRaf-1 (Figure 1a) . Surprisingly, activation of endogenous A-Raf in the same cells was virtually nonresponsive to transfection of oncogenic Ha-Ras (Figure 1b ). This observation suggested that A-Raf might not be the primary target of active Ras within the cell. Since binding to Ras at the plasma membrane represents a critical step in the activation of Raf (Leevers et al., 1994; Stokoe et al., 1994; Daum et al., 1994) we tested whether the observed dierences in activation of endogenous c-Raf and ARaf would be re¯ected in dierent binding anities to Ras.
Binding of Ras to Raf shows isoform speci®city
The primary Ras binding site in Raf is the RBD located in the ®rst conserved domain of Raf. In a ®rst step, binding anity of the individual RBD proteins of A-, B-and c-Raf-1 to members of the Ras family were determined in vitro. The dissociation constants of the dierent Ras/RBD complexes were measured using Ras loaded with the¯uorescent GTP analog mantGpp(NH)p and are compared in Table 1 . Ha-Ras bound to both B-Raf and c-Raf-1-RBD with similar anity, while Ha-Ras binding to ARaf-RBD was signi®cantly reduced. This reduction in binding anity is illustrated by the more than 30-fold increase in the dissociation constant for the Ha-Ras/ARaf-RBD complex in vitro. Moreover, the binding anity of the A-Raf-RBD to other Ras family proteins such as R-Ras, TC21, and Rap1A also showed a signi®cant reduction compared to B-Raf and c-Raf-1 (Table 1 ). These observations are further supported by in vivo binding assays using full-length c-Raf-1 or ARaf in the yeast two-hybrid system. Protein interaction was quanti®ed using b-galactosidase activity as previously described (Jaitner et al., 1997) . b-galactosidase activity induced by binding of full-length A-Raf to Ha-Ras was reduced to about 25% of the c-Raf-1 Values were obtained by measuring the inhibition of the dissociation of mant-Gpp(NH)p from the Ras protein at 378C as described in Materials and methods. Dissociation constants of complexes between RGF and Ras proteins were determined as described . N.D. not determined level ( Figure 2a (Nassar et al., 1995; Herrmann and Nassar, 1996b) .
Since the residues at corresponding positions 64, 66, 67, 68, 84, and 89 in c-Raf are identical for all three Raf isozymes (Figure 3a ), we hypothesized that the amino acid dierence at position 59 in c-Raf (which corresponds to residue 22 in A-Raf) would be a candidate for isoform discrimination in Raf activation by Ras. Crystallographic and functional studies revealed that Arg 59 in c-Raf interacts with Glu 37 of Ha-Ras or Rap1A (Figure 3b ) , and we have demonstrated that this interaction provides a major contribution to the Ha-Ras/Raf binding anity Jaitner et al., 1997) . To test the hypothesis that the exchange from Arg to Lys at the corresponding position 22 in A-Raf was responsible for the reduced anity, we mutated Arg 59 in c-Raf to lysine and performed in vitro binding studies with isolated RBDs. c-RafRBD-R59K reduced its binding anity to Ha-Ras to the level of the A-Raf RBD (Table 1) . In a reverse experiment, we mutated the corresponding Lys 22 in the A-Raf RBD to arginine and tested the binding capacity in vitro. Compared to the wildtype RBD, the mutant form (A-RafRBD-K22R) displayed a twofold increased binding anity to Ha-Ras (Table 1) . To further support these observations we performed in vivo binding assays using full length Raf isoforms in a yeast two hybrid assay (Jaitner et al., 1997) . The R-K mutation at residue 59 in c-Raf led to a 50% reduction in its in vivo binding anity to Ha-Ras compared to wildtype (Figure 2b ), whereas the corresponding K-R mutation at position 22 in A-Raf increased its binding anity (Figure 2c ).
Dierential binding anities aect Raf signaling
To assess functional consequences of the point mutations in vivo, we tested the Ras-induced activity of wild-type and mutant c-Raf-1. HEK 293 cells were co-transfected with oncogenic Ha-Ras-G12V and HAtagged versions of either wildtype c-Raf-1 or various point mutants (c-Raf-R59K, c-Raf-R89L). Ha-Ras-G12V increased wildtype Raf activity more than 15-fold over baseline, measured by phosphorylation of recombinant kinase dead MEK in an in vitro kinase assay ( Figure 4a ). In concordance with previously published results, mutation at position 89 abolishes Ras-induced Raf activity (Melnick et al., 1993; Fabian et al., 1994) . When we tested the Ha-Ras-G12V induced kinase activity of the c-Raf-R59K mutant, we found that the exchange from Arg 59 to Lys 59 resulted in an approximately 50% decrease of kinase activity compared to c-Raf-1 wild-type (Figure 4 ). In addition, we analysed the eects of mutant Raf proteins on transcriptional activation. We employed transient transfection assays in RK13 cells using a luciferase reporter gene driven by three E74 binding sites as a read out system (Jahnknecht et al., 1993) . This Ets binding site mediates transcription upon activation of the Ras/Raf/MEK/ERK pathway . In this system co-transfection of oncogenic Ha-Ras with wildtype c-Raf resulted in a nearly 40-fold transactivation of the reporter gene ( Figure 5 ). In contrast, transfection of c-Raf-R59K reduced the ability of Ha-Ras-G12V to induce transcriptional activity more than 50%. We further tested whether the observed increase in binding anity for the corresponding A-Raf mutant (A-Raf-K22R) resulted in an higher catalytic activity. We used dierent concentrations of Ha-Ras to mimic the endogenous situation where little or no A-Raf is activated by transfection of Ras. Under these conditions we show that the Ha-Ras induced kinase activity of A-Raf-K22R is signi®cantly increased compared to the wildtype ( Figure 6 ). In summary, our data suggest that distinct binding anities lead to preferential signaling of oncogenic Ha-Ras through cRaf-1 as compared to A-Raf. Thus, the Arg to Lys exchange at residue 59 in c-Raf (or position 22 in ARaf respectively) might act as one point of discrimination for Ha-Ras mediated signaling through Raf isoforms.
Discussion
The binding of Ras to Raf at the plasma membrane represents an important step in the mitogenic signaling cascade, and is a prerequisite for downstream signaling and cellular transformation (Slupsky et al., 1998) . Subsequent events in Raf activation, such as tyrosine phosphorylation appear to be dependent on this membrane localization of Raf. Using mutational analysis of the c-Raf-RBD we have previously shown that in vitro binding anities of Ras for Raf correlate with downstream signaling in vivo (Jaitner et al., 1997; Block et al., 1996) . The present study now provides the ®rst evidence that Ras signaling through Raf isoforms might be regulated by dierential binding anities. We tested the Ha-Ras-induced activation of endogenous c-Raf and A-Raf in HEK293 cells. Transfection with oncogenic Ha-Ras led to a dose dependent activation of c-Raf, whereas A-Raf activity remained virtually unaected. Several studies indicate that the regulation of tyrosine phosphorylation is similar for c-Raf and A-Raf (Marais et al., 1997; Bosch et al., 1997) , but this raises the question of how the observed dierential signaling through c-Raf versus A-Raf is achieved. Since tyrosine phosphorylation is believed to be a consequence of membrane recruitment, the regulation of the Ras-Raf binding would be a key step in isozyme speci®c signaling, i.e. preferential binding of Ras to c-Raf would lead to preferential Structure of the c-RafRBD/Ra* complex. Ra* represents the Rap1-E30D-K31E double mutant a protein with a chrystallographic structure similar to Ras with an identical core eector region . Amino acid Arg59 in RafRBD and its interaction partner Glu37 in Ra* are highlighted and the side chain interactions are indicated signaling through this isozyme. We demonstrate that this is indeed the case since the binding anities of RBDs to Ha-Ras in vitro and of full length Raf proteins to Ha-Ras in vivo are higher for c-Raf as compared to A-Raf. In addition, our data indicate that A-Raf-RBD binding anities to other members of the Ras family like Rap1A, R-Ras or TC21 are also reduced compared to those of c-Raf-1-or B-Raf-RBDs (see Table 1 ). While this ®nding is likely due to structural similarities of the small G-proteins tested (Herrmann and Nassar, 1996b) , it also hints to a general predominance of c-Raf-1-and B-Raf-mediated signaling in response to active Ras.
Ras-Raf interaction appears to be mediated by a bipartite contact surface since both the RBD and the CRD have been found to contribute to Ras-Raf binding (Bruder et al., 1992; Zhang et al., 1993; Fabian et al., 1994; Brtva et al., 1995) . Several studies show that the RBD represents the primary binding motif and point mutation of the contact surface residues in the RBD can abrogate or severely impair Ras Raf interaction (Melnick et al., 1993; Fabian et al., 1994; Block et al., 1996) . Since we wanted to determine the eect of the Arg/Lys exchange in the complete Raf kinase we performed in vivo binding assays using full Each bar represents the mean of three independent experiments, the error of the experiment was within 10% length molecules. We found that the dierences in binding anities of full length Raf isoforms correlate well with changes in binding anities determined using the isolated RBDs. This is further supported by our mutational analysis which demonstrate that the Arg/ Lys exchange at position 59 in the c-Raf-1 RBD provides one point for isozyme discrimination. Although residue 59 forms a key contact, there are more amino acid dierences between the RBDs of cRaf-1 and A-Raf. The role of other residues is re¯ected in the observation that the reverse K to R mutation at position 22 of A-Raf cannot fully compensate for the dierences between A-Raf and c-Raf-1 in vivo and in vitro. Furthermore, there is a signi®cant dierence in Ras binding anity between the c-Raf and B-Raf RBD, both have arginines at the corresponding positions. It also remains speculative whether the CRD is also involved in dierential binding of Raf isoforms. We have shown that the CRD contributes only a minor part to the total binding anity, and that single point mutations of surface residues of the CRD lead neither to a drastic decrease of Ras-Raf binding nor Raf activation (Daub et al., 1998) . Thus, it appears safe to attribute part of the isoform speci®city in Raf Binding by Ras to the Arg/Lys exchange in at position 59 in the c-Raf RBD.
Arg 59 in c-Raf forms a salt bridge with Glu 37 in HaRas by bidentate binding of the guanidinium group with the carboxylate group of Glu 37 ( Figure 3b ) . Since Lysine can only form a single side chain contact, we suggest that the reduced contribution of Lys 22 in A-Raf is responsible for the observed reduction of binding anity of A-Raf to HaRas. This conclusion is supported by previous experiments using CD-spectroscopy, which show that the dierent binding anities of surface mutants are not due to changes in the integral structure of the RBD . We can further demonstrate that a point mutation of Lys 22 to Arg results in an increased binding of A-Raf to Ha-Ras in vivo and in vitro (Table  1 and Figure 2c ) suggesting that an arginine at position 22 (in A-Raf) is able to partially restore binding to HaRas.
To relate dierential Ras-Raf binding to Raf activation in vivo, we employed transient transfection assays in HEK293 and RK13 cells. Downstream signaling correlates with dierent binding anities. Cotransfection of oncogenic Ha-Ras results in opposite eects: the R59K mutant of c-Raf shows decreased activation compared to wildtype, whereas the K22R mutant in A-Raf has a higher Ha-Ras-induced catalytic activity compared to wildtype A-Raf. This eect is particularly pronounced under conditions where little A-Raf is activated by Ras. These ®ndings underline the importance of the Ras-Raf interaction in the regulation of the mitogenic signaling cascade, and suggest that Ras mediated signaling would always prefer to activate B-Raf or c-Raf rather than A-Raf in cells where multiple isoformes are expressed. Since the tissue distribution of A-Raf is more restricted compared with c-Raf (Storm et al., 1990; Pritchart et al., 1996) , it is reasonable to assume that in A-Raf expressing cells c-Raf is also present. In HEK293 cells Ha-Ras failed to activate endogenous A-Raf. Moreover the decreased binding anities of A-Raf to various tested Ras family proteins might re¯ect a generally lower responsiveness of the A-Raf isozyme. This leaves the question whether Ras represents the physiological activator for A-Raf.
Several lines of evidence exist that Ras-mediated signaling through Raf is regulated on dierent levels. It has been recently reported that maximal activation of B-Raf can be achieved by GTP-loaded Ras alone, whereas both A-Raf and c-Raf-1 require co-stimulatory tyrosine kinases (Marais et al., 1997) . Recent evidence shows that dierent Ras isoforms are also able to exhibit various eector preferences (Yan et al., 1998) indicating a complex network of signal generation. Our data describe an additional level of regulation achieved by dierent binding anities of A-Raf and c-Raf to Ras.
Materials and methods

Protein expression and puri®cation
The construction of the expression vector for GST-Raf-RBD and expression and puri®cation of wildtype and mutant RafRBDs have been described previously . Ha-Ras protein was prepared as described before (John et al., 1988) .
Measurement of Ras-RafRBD interaction
RafRBD acts as a nucleotide dissociation inhibitor for Ras (Herrmann et al., 1996a) . The anity of wildtype RafRBD and RafRBD mutants for Ras was therefore determined by titrating Ras loaded with the¯uorescent mant-Gpp(NH)p nucleotide with RafRBD proteins. The dissociation rate constants of nucleotide dissociation from Ras were used to determine the Ras-RafRBD interaction. Dissociation constants were determined in 50 mM Tris/HCl, 5 mM MgCl 2 , pH 7.4. For measurement of the Ras-RafRBD interaction, 25 nM Ras-mant-Gpp(NH)p complex was incubated with a 1000-fold excess of unlabeled nucleotide and dierent concentrations of RafRBD, and the dissociation was measured as a decrease in¯uorescence. The dissociation constants were obtained by ®tting the data to single exponentials. Details of this procedure have been described (Herrmann et al., , 1996a .
Construction of plasmid DNAs
A 11 amino acid hemagglutinine (HA) tag (amino acid sequence MAYPYDVPDYA) was introduced in-frame into N-terminal Nhe1 and Nde1 restriction sites of c-Raf wildtype (wt) in KRSPA using heteroduplexed oligonucleotides (Cravchick and Matus, 1993) . HA-Raf-1 inserts were subcloned into pcDNA3 (Invitrogen) using the HindIII and Xba restriction enzymes. A triple HA-tag was fused in-frame to the C-terminus of PUC19-A-Raf (Beck et al., 1987) . ARaf-HA was subcloned into pcDNA3 (Invitrogen) using the appropriate restriction sites. Point mutations R59K of c-Raf-1 and K22R of A-Raf were generated by site directed muatgenesis using the Quick change mutagenesis kit (Stratagene). The N-terminal portion of pcDNA c-Raf-R89L was ampli®ed by polymerase chain reaction (PCR) using the following primer: upstream 5'-ACGCTAGCCTTG-GAGCACATACAGGGAGC-3', reverse 5'-GTCACA-GAAGGCAAGCTTCAGGAACGTC-3'.
PCR-products were subcloned into wt HA-tagged cRaf-1 to yield and HA-cRaf-R89L in pcDNA3. Sequence integrity of all plasmids was con®rmed by sequencing using an automated DNA sequencer (ABI-system). The following expression vectors and constructs have been previously described: pEQ176 (Jahnknecht et al., 1993) , ERK-1 (Daub et al., 1998) , pSG-ER81 (Jahnknecht, 1996) , Ha-Ras-G12V, pcDNAc-Raf-R89L , pEQ176 and E74 3 -tk80-luc (Jahnknecht et al., 1993) . The two-hybrid Ras constructs were generated by PCR ampli®cation of Ras residues 1 ± 166 or of full length Ras using the Ras-G12V template (Jaitner et al., 1997) . Ras constructs were cloned into the pPC97 DNA binding domain fusion vector (Chevray and Nathans, 1992) . c-Raf (wt), c-Raf-R59K, A-Raf (wt) and A-Raf-K22R that were generated in pcDNA3, were cloned into pPC86 GAL4 activation domain fusion vector or into pGEX-Raf-RBD as previously described (Daub et al., 1998; Jaitner et al., 1997) .
Yeast two-hybrid assays
The two-hybrid system employed in this study was developed by Chevray and Nathans (1992) and modi®ed here by using the yeast strain Y190. For binding studies with Raf and HaRas-G12V 1 ± 166 , competent yeast cells prepared as described (Jaitner et al., 1997) , were co-transformed with 1 ng of each of the two-hybrid vectors and grown on synthetic medium lacking leucine, tryptophane and histidine and containing 25 mM 3-amino-1,2,3-triazole (3-AT; Sigma) to monitor interaction between the fusion proteins. Quantitative twohybrid assays were performed using a modi®ed protocol based on the procedure previously described (Daub et al., 1998; Jaitner et al., 1997) . Original transformants were restreaked on selective plates. From these plates colonies were inoculated in selective medium. The liquid cultures were incubated at 308C until they reached an OD 600 of 0.5 ± 1.0. Yeast cells were lysed by adding 50 ml CHCl 3 and 50 ml 0.1% (w/v) sodium dodecyl sulfate to 800 ml of resuspended cells as described (Daub et al., 1998) . The b-galactosidase activity in this lysate was measured using the Galacto-Star chemiluminescent yeast reporter assay kit according to the instructions of the manufacturer (Tropix). Relative b-galactosidase activity was obtained by normalizing luminescence to the OD 600 .
Raf kinase assay
HEK 293 cells were grown to 50% con¯uency and transfected using the calcium phosphate coprecipitation method. Five mg of empty pcDNA plasmid or the indicated Raf construct in pcDNA3 were used together with indicated amounts of the Ha-Ras-G12V expressing construct. Cells were starved for 36 h in DMEM containing 0,3% FCS and harvested 48 h after transfection. To assay endogenous Rafkinases, cells were transfected with increasing concentrations of the Ha-Ras plasmid alone. Cells were lysed in NP40 lysis buer (25 mM Tris-HCl, pH 8,0, 150 mM NaCl, 10 mM Napyrophosphate, 25 mM Na-glycerophosphate, 2 mM EGTA, 2 mM EDTA, 10% Glycerol, 0.5% NP40) and cleared by centrifugation at 12 000 g for 30 min. For each immunoprecipitation 5 mg of anti-HA monoclonal antibody (clone 12-CA-5, ATCC) was preabsorbed on protein A agarose beads (Boehringer Mannheim, Germany), and mixed with the lysate for 2 h. To immunopurify endogenous c-Raf or A-Raf, cell lysates were normalized for protein content and split in two equal parts. Immunoprecipitation was performed with isozyme speci®c antisera (Wixler et al., 1996) . Raf kinase assays were performed as previously described using recombinant kinase dead MEK as a substrate (Flory et al., 1998; Daub et al., 1998) . Proteins were separated by 10% SDS ± PAGE and transferred to nitrocellulose membranes. MEK phosphorylation was visualized by autoradiography and analysed with a Phosphoimager (Fuji; Frankfurt, Germany). After exposure, membranes were probed with a rabbit anti-Raf-1 antiserum (Wixler et al., 1996) or an anti-HA monoclonal antibody and developed using enhanced chemiluminescence (Amersham, Braunschweig, Germany) to visualize immunoprecipitated Raf proteins.
Reporter gene assays
Rabbit kidney epithelial-like RK13 cells were grown to 25% con¯uency on 6 cm dishes and then transfected with a total of 10 mg DNA by the calcium phosphate coprecipitation method. Two mg of reporter constructs (E74 3 -tk80-luc), 0.5 mg of a b-galactosidase expression vector (pEQ176), 1.5 mg of ERK-1 expression vector, 1.5 mg of an Ets protein expression vector and 1.5 mg pcDNA3 expression plasmid alone or pcDNA3 expression plasmid containing a respective Raf construct were used for each transfection. Where indicated, 80 ng of the RSV-Ras-G12V plasmid was additionally transfected. Thirty-six hours after transfection, cells were harvested, lysed, and luciferase and b-galactosidase activities were determined as described (Jahnknecht, 1996) . Relative luciferase activity was obtained by normalizing luminescence to b-galactosidase activity.
